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Abstract 
External quality assurance (EQA) provides ongoing evaluation to verify that laboratory medicine results 
conform to quality standards expected for patient care. While attention has focused predominantly on 
test accuracy, the diagnostic phases, consisting of pre- and post-laboratory phases of testing, have thus 
far lagged in the development of an appropriate diagnostic-phase EQA program. One of the challenges 
faced by Australian EQA has been a lack of standardisation or "harmonisation" resulting from variations in 
reporting between different laboratory medicine providers. This may introduce interpretation errors and 
misunderstanding of results by clinicians, resulting in a threat to patient safety. While initiatives such as 
the Australian Pathology Information, Terminology and Units Standardisation (PITUS) program have 
produced Standards for Pathology Informatics in Australia (SPIA), conformity to these requires regular 
monitoring to maintain integrity of data between sending (laboratory medicine providers) and receiving 
(physicians, MyHealth Record, registries) organisations' systems. The PITUS 16 Informatics EQA (IEQA) 
Project together with the Royal College of Pathologists of Australasia Quality Assurance Programs 
(RCPAQAP) has created a system to perform quality assurance on the electronic laboratory message 
when the laboratory sends a result back to the EQA provider. The purpose of this study was to perform a 
small scale pilot implementation of an IEQA protocol, which was performed to test the suitability of the 
system to check compliance of existing Health Level-7 (HL7 v2.4) reporting standards localised and 
constrained by the RCPA SPIA. Here, we present key milestones from the implementation, including: (1) 
software development, (2) installation, and verification of the system and communication services, (3) 
implementation of the IEQA program and compliance testing of the received HL7 v2.4 report messages, 
(4) compilation of a draft Informatics Program Survey Report for each laboratory and (5) review 
consisting of presentation of a report showing the compliance checking tool to each participating 
laboratory. 
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Abstract: External quality assurance (EQA) provides ongo-
ing evaluation to verify that laboratory medicine results 
conform to quality standards expected for patient care. 
While attention has focused predominantly on test accu-
racy, the diagnostic phases, consisting of pre- and post-
laboratory phases of testing, have thus far lagged in the 
development of an appropriate diagnostic-phase EQA pro-
gram. One of the challenges faced by Australian EQA has 
been a lack of standardisation or “harmonisation” result-
ing from variations in reporting between different labora-
tory medicine providers. This may introduce interpretation 
errors and misunderstanding of results by clinicians, result-
ing in a threat to patient safety. While initiatives such as the 
Australian Pathology Information, Terminology and Units 
Standardisation (PITUS) program have produced Standards 
for Pathology Informatics in Australia (SPIA), conformity to 
these requires regular monitoring to maintain integrity of 
data between sending (laboratory medicine providers) and 
receiving (physicians, MyHealth Record, registries) organi-
sations’ systems. The PITUS 16 Informatics EQA (IEQA) 
Project together with the Royal College of Pathologists of 
Australasia Quality Assurance Programs (RCPAQAP) has 
created a system to perform quality assurance on the elec-
tronic laboratory message when the laboratory sends a 
result back to the EQA provider. The purpose of this study 
was to perform a small scale pilot implementation of an 
IEQA protocol, which was performed to test the suitability 
of the system to check compliance of existing Health Level-7 
(HL7 v2.4) reporting standards localised and constrained 
by the RCPA SPIA. Here, we present key milestones from 
the implementation, including: (1) software development, 
(2) installation, and verification of the system and commu-
nication services, (3) implementation of the IEQA program 
and compliance testing of the received HL7 v2.4 report mes-
sages, (4) compilation of a draft Informatics Program Sur-
vey Report for each laboratory and (5) review consisting of 
presentation of a report showing the compliance checking 
tool to each participating laboratory.
Keywords: external quality assurance (EQA); Informat-
ics EQA; interoperability conformance testing; laboratory 
medicine report standardisation; messaging; patient safety.
Introduction
Researchers from the Royal College of Pathologists of Aus-
tralasia Quality Assurance Programs (RCPAQAP) and Mac-
quarie University recently published a paper describing 
the importance of pre- and post-laboratory phases which 
form the diagnostic phases of laboratory medicine testing 
[1]. The issues, however, have been known of in Australia 
since at least 1996 [2]. These phases “beyond the lab” 
constitute a major source of errors that reduce laboratory 
effectiveness and threaten patient safety [1, 3]. External 
quality assurance (EQA) ensures that verification is per-
formed on a recurring basis, and that laboratory results 
conform to expectations for quality required for patient 
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care [4]; however, most Australian laboratories have pre-
viously focused narrowly on laboratory processes such as 
test accuracy and precision [1]. Until recently, it was very 
difficult to quantify the number and magnitude of errors 
in the extra-analytical phases due to a lack of formal EQA 
measures in these areas.
Detection of these errors requires reliable quality indi-
cators during the total testing process (TTP), from the time 
the laboratory request is determined, until the clinician 
receives the final report, makes a diagnosis and decides on 
the appropriate action [3, 5, 6]. Launched in 2008, the Key 
Incident Monitoring and Management System (KIMMS) 
is an Australasian-developed quality improvement (QI) 
program that records incidents (process defects) and epi-
sodes (occasions where incidents may occur) while also 
assigning quantified risk to each incident type (by multi-
plying by harm rating and detection difficulty score) using 
failure mode effects analysis (FMEA) [5]. By 2016 KIMMS 
had detected over 200  million episodes and 2.9  million 
incidents, detecting an overall TTP incident rate of 1.75% 
[5]. Some incident rates may appear low, but when taking 
into account risks and their frequencies, critical incident 
types emerge that require improvements in management. 
For example, haemolysis had both the highest incidence 
(22.6% of total incidents) and highest risk (26.68% of total 
risk). However, incidents that have low frequency (e.g. 
“sample suspected to be from wrong patient” had the 
second lowest score) but high harm rating (e.g. 10/10) and 
detection difficulty scores (10/10) end up having a rela-
tively higher risk to reflect the severity of potential risk to 
the patient [5]. Until recently, KIMMS has focused mainly 
on the pre-laboratory phase of the TTP cycle, thus there 
has been a need to create an EQA program that encom-
passes the post-laboratory phase.
One of the major post-laboratory areas that has been 
under urgent pressure for improved EQA measures has 
been laboratory reporting, especially given the wide-
spread adoption of electronic health records which aggre-
gate reports from multiple laboratories, such as MyHealth 
Record in Australia [7]. The importance for standardisa-
tion or “harmonisation” of the formats and styles used in 
clinical chemistry reporting is key to interoperability and 
safety for electronic health records [8–10]. Significant var-
iations in reporting policies between different Australian 
laboratory medicine providers, or even within the same 
provider, result in different styles of reports for different 
customers [11]. The clinical chemistry report needs to be 
clear and unambiguous; however, in Australia there are 
still differences in reporting, e.g. different names for the 
same test, different units, different tests included in panels 
with the same names, differences in reference intervals 
(RIs) and flagging of results outside limits [12]. These dif-
ferences may introduce misunderstanding resulting in 
interpretation errors by clinicians or patients at the post-
laboratory phase [10, 13], which is a patient safety issue. 
Activities aiming to increase harmonisation in laboratory 
medicine include improving metrological comparability 
of results, as well as reducing unnecessary between-labo-
ratory variation in test requesting and reporting [9], which 
is the focus of our trial.
The Australian Pathology Units and Terminology 
Standardisation (APUTS) project [12] began in 2011 and 
was the first of three projects completed in a program of 
laboratory medicine informatics standardisation led by 
the RCPA but which had active involvement from many 
organisations and individuals. The program is now called 
PITUS (Pathology Information Terminology and Units 
Standardisation) – a fourth phase has been planned but 
awaits funding. The consensus standards developed in 
PITUS have been endorsed and published by the RCPA 
as college policy – the version at the time of writing was 
called Standards for Pathology Informatics in Australia 
(SPIA) v3.0 [14, 15]. It includes requesting and reporting 
terminology including preferred Australian terms, stand-
ardised units, safe report rendering, information models 
and harmonised RIs and best practice guidance for safe 
laboratory medicine requesting and reporting. One of 
the six sub-projects for PITUS 16 was a trial implementa-
tion of an Informatics EQA (IEQA) program, therefore the 
purpose of this study was to evaluate a small scale pilot 
implementation of an IEQA program in order to study the 
feasibility for large scale implementation. This sub-project 
endeavoured to create a system to perform quality assur-
ance on the electronic laboratory message when the labo-
ratory sends a result back to the EQA provider itself. This 
was a follow-on to a previous (PITUS-14) sub project which 
investigated a more manual evaluation of instances of the 
implementation of standards for requesting and reporting 
working with the largest private and largest public labora-
tories in Australia and with active co-operation from the 
Medical Software Industry Association and the National 
EHealth Transition Authority [8, 11, 16].
Pre- and post-laboratory errors
Pre- and post-laboratory errors may have serious conse-
quences for patients and place unnecessary cost on the 
medical system. Pre-laboratory errors include errors 
in ordering tests, preparing patients and processing 
samples, and post-laboratory errors may occur during 
reporting results to physicians, interpretation of results 
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by physicians, notification of results to patients, adminis-
tration and communication [17]. A study by the American 
Academy of Family Physicians reported that at least 18% of 
patients experienced some form of harm in a study of 966 
pre- and post-laboratory errors [17]. In addition to harm, 
further outcomes included delays in care (24%), financial 
consequences and time wasted (22%), pain and suffering 
(11%) and adverse clinical consequence (2%) [17].
An Australian study has outlined performance criteria 
for the post-laboratory phase, highlighting a need for the 
post-laboratory phase to take “quality technical results 
and provide the means for clinical interpretation in the 
report” [18]. For example, RIs are often used in interpre-
tation particularly at diagnosis, but different laboratories 
may use different RIs, even in cases of similar methods 
[18, 19]. An evidence-based approach was developed by 
scientific consensus at workshops of the Australasian 
Association of Clinical Biochemists (AACB) between 2012 
and 2014, resulting in the development of the “AACB Har-
monised Reference Intervals” [19]. While laboratories 
were consulted, adoption of RIs still lies with each labo-
ratory. Reaching harmonisation would result in consist-
ency of RIs across Australia and New Zealand. Sikaris has 
expanded on the ISO15189  standard definition of post-
laboratory phase (the processes following the examina-
tion, including review of results) [20] to incorporate the 
quality of clinical chemistry reports, including formatting, 
releasing, reporting and retention of examination results 
for future access [18]. It is also recommended that quality 
in post-laboratory interpretation should take into account 
not only quality analytical data, but also its interpretation 
against the patient’s clinical context [18]. This is crucial 
because the misinterpretation of test results may have 
many contributors, namely cognitive factors, RIs, clinical 
interpretations and notifications from laboratory special-
ists, all of which may contribute to misdiagnosis [21–23].
An Informatics EQA (IEQA) program 
for the post-laboratory phases
With physicians often receiving clinical chemistry reports 
electronically from different laboratories, there is a risk 
that variations in reporting formats may add a layer of 
complexity in interpreting the report, or result in errors 
which can result in a risk to patient safety [24]. Audit and 
dissemination of harmonisation guidelines on their own 
have been shown to be insufficient in managing quality 
of results interpretation in general practice, and EQA 
studies have shown variability between clinicians’ inter-
pretation of clinical chemistry results for specific tests 
[25–27]. Therefore, it is crucial that: 1) standards are actu-
ally implemented; and 2) conformity to the standards and 
guidelines is continuously assessed. The RCPAQAP aims 
to implement an IEQA program to ensure ongoing quality 
and safety in reporting.
A trial implementation of the IEQA program
Compliance and standardisation of laboratory medicine 
terminology are needed to maintain integrity of data 
shared between sending (laboratory medicine providers) 
and receiving (physicians, MyHealth Record, registries) 
organisations’ digital health information systems. The 
RCPA PITUS 16 Project Working Group 6 collaborated with 
RCPAQAP to design and analyse a system for reporting 
data using an IEQA program, the architecture of which is 
outlined in Figure 1.
In 2015, as part of the RCPAQAP Liquid Serum Chem-
istry (LSC), program, laboratories were invited to supply a 
routine paper report displaying results. The LSC program 
is a commutable frozen patient serum program used to 
assess method differences. The RCPAQAP then analysed 
these reports against the SPIA (formerly known as the 
RCPA APUTS v2.3 standard) [28], and variations were iden-
tified [29]. This provided validation for the rationale for 
development and trial of an IEQA protocol to test compli-
ance of existing Health Level-7 (HL7) reporting standards 
with reporting standards developed by the RCPA [1, 30]. 
Accrediting bodies such as the National Association of 
Testing Authorities, Australia (NATA) could then use this 
to assist with compliance. Medical Objects Pty Ltd [31], a 
medical software vendor, was selected after formal evalu-
ation of responses to a call for expressions of interest. The 
evaluation software was co-designed. The system built 
was capable of sending standardised electronic request 
messages and receiving electronic report messages and 
then analysing the message received. Message services 
supported Secure Message Delivery (SMD)-based secure 
messaging. Two laboratories volunteered to send HL7 v2 
report messages with atomic clinical chemistry results 
for the RCPAQAP LSC program. These sites represented 
two of the major laboratory information systems (LIS) in 
use in Australia and serviced both hospital and commu-
nity patients and hence were sending results to multiple 
Hospital Information Systems and General Practitioner 
practice systems. The Medical Objects’ software tool was 
used by RCPAQAP to test compliance of the HL7 v2 report 
messages received from each laboratory against the HL7 
Messaging Standard Version 2.4 [32], Australian Stand-
ard AS4700.2:2012 [33] and RCPA APUTS v2.3  standards 
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[34] (an earlier version of SPIA [28] but with most of the 
same compliance points). A mock RCPAQAP Informatics 
Program Survey Report was designed and then compiled 
for each of the laboratories, reporting on an assessment 
of the validity, integrity and rendered form of the data 
received.
Key milestones of the IEQA trial
Key milestones of the IEQA trial are listed and described 
in Table 1.
Issues around the implementation
In the IEQA trial, the participating laboratories were 
sent and could receive the electronic request message, 
but their LIS were not configured to process it. Electronic 
laboratory requesting was not the main focus of the trial 
and although electronic laboratory requesting is techni-
cally possible, more work is required by the RCPAQAP 
to find the best solution for how to communicate the 
60+ systematized nomenclature of medicine-clinical 
terms Australia codes for the individual analytes of the 
RCPAQAP LSC program in an electronic request message. 
Participating laboratories would also need to configure 
their laboratory information system to process these 
codes. 
As for other EQA programs the IEQA still needs a 
subject matter expert to be involved in running the EQA 
round. In this case that means a laboratory medicine 
informatician familiar with messaging standards and 
reporting requirements. 
The lack of a significant industry driver to encourage 
laboratories to configure their LIS to receive a standard-
ised electronic request message remains a barrier. This 
barrier would be overcome if there was an IEQA in place 
to identify those laboratories that were not using the SPIA 
standards.
Another issue is that patients have the freedom to 
select which collection centre they have their samples col-
lected, and that collection centre may not belong to the 
laboratory suggested by the requestor. The lack of a cen-
tralised laboratory medicine order message broker means 
there is no direct link between requestors (e.g. physicians) 
and the laboratory performing the service. The adoption 
of standards for laboratory medicine informatics by the 
clinical chemistry accreditation scheme [National Pathol-
ogy Accreditation Advisory Council (NPAAC)] and/or for 
requesting a common request hub would drive standardi-
sation in the right direction.
RCPA QAP Laboratory
Co-ordination IVD EQA
request receipt
Request for testing
Report of IVD findings
Report
 of MCT
Report of IVD findings
IVD testing in
department
NPAAC
Standards Australia
RCPA policy
Standards
Message
conformance testing
Informatics testing
KIMMS program
Informatics EQA
program
IVD EQA program
Figure 1: High-level IEQA architecture. IVD,  in vitro diagnostic; MCT, message conformance testing.
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Table 1: Key milestones of the IEQA trial.
Key milestone   Stages
1.  Development of the 
software by Medical 
Objects. Two new 
software modules for 
the trial implementation, 
including:
  1.  Multi-component test requests (e.g. liver function test) (electronic requesting of clinical chemistry 
request orders)
2.  Quality assurance-compliance rule checking module for HL7 v2.4 report messages against HL7 
Messaging Standard v2.4 and AS4700:2:2012 standard; atomic data in HL7 v2.4 report messages 
against SPIA, including checking LOINC code, preferred term, reference interval, flagging, alignment 
and units
2.  Installation, setup 
and verification of the 
system software and 
communication services
  a)  Medical Objects “Explorer” software application installed on computers used for compliance testing
b)  Medical Objects’ “Eclipse” communication services used during the trial implementation to 
electronically send HL7 v2.4 request messages to the participating laboratories as well as receive 
HL7 v2.4 report messages from the participating laboratories
3.  Implementation of 
the IEQA program and 
compliance testing of the 
received HL7 v2.4 report 
messages
  a)  Using bulk orders module, a clinical chemistry test request for Liquid Serum Chemistry program was 
created and an electronic HL7 v2.4 request was electronically transmitted to the two laboratories. 
Also sent a PDF version of clinical chemistry request form via email
b)  The participating laboratories electronically transmitted HL7 v2.4 report messages with the results 
to RCPAQAP for analysis
c)  Quality assurance module performed compliance rule checks on each received HL7 v2.4 report 
messages. Assessed
a.  Compliance of HL7 v2.4 report message against the HL7 Messaging Standard v2.4 and AS4700.2: 
2012 standard, including compliance to conformance points in the AS4700:2:2012 standard
b.  Compliance of atomic result data in the HL7 v2.4 report messages against terminology standards 
(LOINC code, preferred term, reference interval and units) and harmonised reference intervals 
described within SPIA [15] (Figure 2)
c.  In the quality assurance module, windows were also provided for the tester to perform manual 
comparison of the rendered clinical chemistry report against the expected SPIA format, which is 
important for certain SPIA standards that require manual checking (Figure 3)
4.  Compilation of a draft 
Informatics Program 
Survey Report
  a)  These were provided to each laboratory that participated, to assist them in identifying compliant 
areas and areas requiring further improvement
5.  Review of trial 
implementation
  a)  Presentation of report showing the compliance checking tool to each participating laboratory
LOINC, Logical Observation Identifiers Names and Codes.
Figure 2: Example of compliance rule check for the atomic result data against the RCPA published SPIA.
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Use of ICT to support EQA in diagnostic phase 
and following up test results – does informa-
tion technology (IT) enhance follow-up?
Our team’s previous research has demonstrated that 
health Information and Communications Technology 
(ICT) can be used to support EQA by standardised result 
reporting, but it can also be useful in other clinical appli-
cations. For example, electronic test acknowledgement 
systems may help to reduce incidence of missed test 
results [35] and electronic decision support systems can 
be used to improve the quality of result interpretation, by 
alerts specific to the patient on adhering to clinical guide-
lines or protocols [36]. Thus, we believe that it is feasible 
to use EQA to study compliance to standards on request-
ing and reporting lab tests.
Conclusions
For laboratory medicine services to provide quality 
post-laboratory services to clinicians and patients, it is 
essential that programs are in place to ensure ongoing 
proficiency of test result reporting as well as standardisa-
tion of test results. Removing barriers to interoperability, 
both between sending (laboratories) and receiving (clini-
cians, MyHealth Record, patients or registries) organisa-
tions is particularly important with the implementation 
of laboratory medicine reports into electronic health 
records. This paper demonstrates the feasibility of an 
IEQA program supported by ICT which has the potential 
to be used by accrediting bodies to assist with compliance 
with PITUS standards and HL7 v2  messaging. This is a 
multi-step process which first drives standardisation and 
that in turn reduces variation which in turn reduces error 
and thereby harm. Expansion of this IEQA program to a 
large scale implementation across Australia will reveal its 
true benefits in improving communication, standardisa-
tion and patient safety in laboratory medicine in the era of 
electronic health records.
The described IEQA model could be used in any 
country where there is electronic transmission of requests 
and results. In Australia, there are guidelines for the 
format of reports and the transmission of results, these 
would need to be in place as well. This is a key initiative 
to reduce this under-recognised post-laboratory error. We 
believe that EQA providers in each country could develop 
a similar IEQA in the interests of patient safety.
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